Cargando…

Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy

OBJECTIVE: We aimed to investigate the potential risk factors for residual lesions after uterine artery chemotherapy and embolization (UACE) in combination with dilatation and curettage (D&C) in patients with cesarean scar pregnancy (CSP). SETTINGS: Retrospective case-control study. METHOD: Univ...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Feng, Shan, Dan, Guo, Sijia, Cheng, Shuang, Yang, Hongwei, Han, Jialin, Hu, Tongxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040523/
https://www.ncbi.nlm.nih.gov/pubmed/31195943
http://dx.doi.org/10.2174/1566524019666190612135728
_version_ 1783501007041331200
author Cheng, Feng
Shan, Dan
Guo, Sijia
Cheng, Shuang
Yang, Hongwei
Han, Jialin
Hu, Tongxiu
author_facet Cheng, Feng
Shan, Dan
Guo, Sijia
Cheng, Shuang
Yang, Hongwei
Han, Jialin
Hu, Tongxiu
author_sort Cheng, Feng
collection PubMed
description OBJECTIVE: We aimed to investigate the potential risk factors for residual lesions after uterine artery chemotherapy and embolization (UACE) in combination with dilatation and curettage (D&C) in patients with cesarean scar pregnancy (CSP). SETTINGS: Retrospective case-control study. METHOD: Univariate analysis and logistic analysis were applied to analyze these data to assess the risk factor of residue after UACE in combination with D&C. RESULTS: Gestational age, human chorionic gonadotropin (HCG) level, and the gestation sac (GS) evagination to the bladder were the risk factors for the postoperative lesion. The most relevant was GS evagination to the bladder, followed by the preoperative HCG level and the gestational age. We defined the cut-off value of gestational age as 28 days with a sensitivity and specificity of 100 and 0, respectively. CONCLUSION: In cases with GS evagination to bladder and HCG of >28,113.65 mIU/ml as well as a gestational age of >28 days, the possibility of residual lesions was high.
format Online
Article
Text
id pubmed-7040523
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-70405232020-03-13 Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy Cheng, Feng Shan, Dan Guo, Sijia Cheng, Shuang Yang, Hongwei Han, Jialin Hu, Tongxiu Curr Mol Med Article OBJECTIVE: We aimed to investigate the potential risk factors for residual lesions after uterine artery chemotherapy and embolization (UACE) in combination with dilatation and curettage (D&C) in patients with cesarean scar pregnancy (CSP). SETTINGS: Retrospective case-control study. METHOD: Univariate analysis and logistic analysis were applied to analyze these data to assess the risk factor of residue after UACE in combination with D&C. RESULTS: Gestational age, human chorionic gonadotropin (HCG) level, and the gestation sac (GS) evagination to the bladder were the risk factors for the postoperative lesion. The most relevant was GS evagination to the bladder, followed by the preoperative HCG level and the gestational age. We defined the cut-off value of gestational age as 28 days with a sensitivity and specificity of 100 and 0, respectively. CONCLUSION: In cases with GS evagination to bladder and HCG of >28,113.65 mIU/ml as well as a gestational age of >28 days, the possibility of residual lesions was high. Bentham Science Publishers 2019-08 2019-08 /pmc/articles/PMC7040523/ /pubmed/31195943 http://dx.doi.org/10.2174/1566524019666190612135728 Text en © 2019 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Cheng, Feng
Shan, Dan
Guo, Sijia
Cheng, Shuang
Yang, Hongwei
Han, Jialin
Hu, Tongxiu
Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy
title Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy
title_full Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy
title_fullStr Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy
title_full_unstemmed Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy
title_short Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy
title_sort risk factor for residue after uterine artery chemotherapy and embolization in combination with dilatation and curettage for treating caesarean scar pregnancy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040523/
https://www.ncbi.nlm.nih.gov/pubmed/31195943
http://dx.doi.org/10.2174/1566524019666190612135728
work_keys_str_mv AT chengfeng riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy
AT shandan riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy
AT guosijia riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy
AT chengshuang riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy
AT yanghongwei riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy
AT hanjialin riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy
AT hutongxiu riskfactorforresidueafteruterinearterychemotherapyandembolizationincombinationwithdilatationandcurettagefortreatingcaesareanscarpregnancy